C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/517 (2006.01) A61K 31/5377 (2006.01) C07D 401/12 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2692502
The present invention provides compounds of Formula (I), including tau-tomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
L'invention concerne des composés représentés par la formule (I), y compris des tautomères, des énantiomères résolus, des diastéréomères, des solvates, des métabolites, des sels et des promédicaments pharmaceutiquement acceptables de ceux-ci. L'invention concerne aussi des procédés d'utilisation des composés de l'invention comme inhibiteurs de protéines kinases AKT et dans le traitement de maladies hyperprolifératives telles que le cancer.
Bencsik Josef
Blake James F.
Graham James M.
Hentemann Martin F.
Kallan Nicholas C.
Array Biopharma Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Genentech Inc.
LandOfFree
Pyrimidyl cyclopentanes as akt protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidyl cyclopentanes as akt protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidyl cyclopentanes as akt protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1762295